03-15-2022 / Learn how CRISPR/Cas9 editing tools support precise mlo gene editing to develop plant varieties resistant to common fungal diseases such as powdery mildew while retaining growth potential and productivity.

02-25-2022 / CRISPR/Cas9 enables targeted genomic insertions, clearing the way for precise therapies for cancer, rare diseases, and more.

12-14-2021 / Learn about the benefits of recently developed CRISPR/Cas tools for engineering T cell therapeutics, including precise modifications, ready-to-use T cell medicines, and improved T cell performance.

10-10-2021 / Learn how CRISPR/Cas9 editing tools have been leveraged to target the SOD1 gene in a mouse model of ALS, preventing the development of ALS pathology.

07-06-2021 / Learn about CRISPR/Cas9-based non-viral knockin for T cell engineering and how the Marson lab at UCSF is optimizing these methods to support T cell therapies.

06-21-2021 / Learn about advances using CRISPR/Cas13 nucleases in viral detection and treatment, including influenza A and SARS-CoV-2.

03-17-2021 / Learn how long stranded DNA (lssDNA) donor templates facilitates knockin CRISPR/Cas9 editing efficiency for animal model generation.

03-11-2021 / Learn how CRISPR/Cas9 gene-editing ex vivo and in vivo approaches are progressing to treat beta-thalassemia, sickle cell disease, Leber congenital amaurosis, and hereditary transthyretin amyloidosis.

11-29-2020 / Novel CRISPR-based Non-viral Approach for CAR T Cell Generation